| P2093 | author name string | J Francis | |
| | W H Jost | |
| | K R Aoki | |
| P2860 | cites work | Inflammation increases the distribution of dorsal horn neurons that internalize the neurokinin-1 receptor in response to noxious and non-noxious stimulation. | Q46304913 |
| | Persistent cardiovascular and behavioral nociceptive responses to subcutaneous formalin require peripheral nerve input | Q46446826 |
| | Antinociceptive effect of botulinum toxin type a in rat model of carrageenan and capsaicin induced pain. | Q46453921 |
| | Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity. | Q46644837 |
| | A lack of antinociceptive or antiinflammatory effect of botulinum toxin A in an inflammatory human pain model | Q46905369 |
| | Peripheral origins and central modulation of subcutaneous formalin-induced activity of rat dorsal horn neurones | Q48170698 |
| | Central nervous system plasticity in the tonic pain response to subcutaneous formalin injection | Q48838894 |
| | The sunburn pain model: the stability of primary and secondary hyperalgesia over 10 hours in a crossover setting | Q48925982 |
| | A further survey of the action of Clostridium botulinum toxin upon different types of autonomic nerve fibre. | Q51058208 |
| | A new method to increase nociception specificity of the human blink reflex. | Q51414760 |
| | Inhibition of release of neurotransmitters from rat dorsal root ganglia by a novel conjugate of a Clostridium botulinum toxin A endopeptidase fragment and Erythrina cristagalli lectin. | Q52861424 |
| | Tetanus toxin and botulinum A toxin inhibit release and uptake of various transmitters, as studied with particulate preparations from rat brain and spinal cord | Q72484204 |
| | Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins | Q73426186 |
| | Botulinum toxin A and the cutaneous nociception in humans: a prospective, double-blind, placebo-controlled, randomized study | Q78454731 |
| | Botulinum toxin type A in experimental neuropathic pain | Q81290805 |
| | Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy | Q28246355 |
| | Regulated exocytosis contributes to protein kinase C potentiation of vanilloid receptor activity | Q28254916 |
| | Neuronal plasticity: increasing the gain in pain | Q29615421 |
| | Vanilloid receptor expression suggests a sensory role for urinary bladder epithelial cells. | Q33949424 |
| | Pain: moving from symptom control toward mechanism-specific pharmacologic management | Q35692291 |
| | A simple pain model for the evaluation of analgesic effects of NSAIDs in healthy subjects | Q35825437 |
| | Thermosensation and pain | Q35884812 |
| | The analgesic potential of clostridial neurotoxin derivatives | Q35925578 |
| | A new wrinkle on pain relief: re-engineering clostridial neurotoxins for analgesics | Q36101373 |
| | Functional aspects and mechanisms of TRPV1 involvement in neurogenic inflammation that leads to thermal hyperalgesia | Q36134913 |
| | Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. | Q36185790 |
| | A randomized, double-blind, placebo controlled study on analgesic effects of botulinum toxin A. | Q39389210 |
| | Botulinum Toxin A reduces neurogenic flare but has almost no effect on pain and hyperalgesia in human skin. | Q39398067 |
| | Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. I. Ultrastructural autoradiographic localization and quantitation of distinct membrane acceptors for types A and B on motor nerves | Q41486002 |
| | Botulinum toxin types A, B and D inhibit catecholamine secretion from bovine adrenal medullary cells | Q42525847 |
| | Insights into a basis for incomplete inhibition by botulinum toxin A of Ca2+-evoked exocytosis from permeabilised chromaffin cells | Q44264839 |
| | Subcutaneous administration of botulinum toxin A reduces formalin-induced pain | Q44722571 |
| | The effects of remifentanil and gabapentin on hyperalgesia in a new extended inflammatory skin pain model in healthy volunteers | Q44741323 |
| | Retargeted clostridial endopeptidases: inhibition of nociceptive neurotransmitter release in vitro, and antinociceptive activity in in vivo models of pain | Q44803129 |
| | Intravesical botulinum toxin a administration produces analgesia against acetic acid induced bladder pain responses in rats | Q45062115 |
| | Rofecoxib attenuates both primary and secondary inflammatory hyperalgesia: a randomized, double blinded, placebo controlled crossover trial in the UV-B pain model | Q45231654 |
| P433 | issue | 5 | |
| P304 | page(s) | 381-2, 384-7 | |
| P577 | publication date | 2006-09-01 | |
| P1433 | published in | Der Schmerz | Q2413522 |
| P1476 | title | [Potential antinociceptive mechanisms of botulinum toxin] | |
| P478 | volume | 20 | |